Enhancing the nanoplasmonic signal by a nanoparticle sandwiching strategy to detect viruses
Source abstract
Abstract
Abstract Nanoparticles that can assemble and bind selectively on surfaces in intricate geometries can trigger multiple plasmonic modalities and enable wide applications in agriculture such as pesticide monitoring, in medical imaging such as targeted cancer detection, in bioengineering such as biotarget detection and biosensing, and in healthcare such as selection of drugs and their binding kinetics. However, these particles mainly rely on binding of the target to a surface to create a plasmonic resonance and subsequent shifts by binding of biotargets, which limit the flexibility to control overall sensitivity. Here, we present an unconventional way that sandwiches a virus (i.e., Hepatitis B virus: HBV) topographically between two or more nanoparticles on the top and the bottom to create a double-step shifting effect amplifying the total resonance wavelength shift on the surface by 1.53 - 1.77 times that significantly enhances the sensitivity. We successfully applied this approach to an intact HBV sensing application, which accurately quantified the viral load. This method establishes a new nanoparticle-based sandwiched nanoplasmonic approach to detect and quantify viral load using two-step sensing with broad applications in biosensing.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bacteriophages and microbial interactions · Animal Virus Infections Studies · Hepatitis B Virus Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Gold nanoparticles in chemical and biological sensing10.1021/cr2001178 ↗
2. Advances in plasmonic technologies for point of care applications10.1021/cr4000623 ↗
3. Cavity optomechanical spring sensing of single molecules10.1038/ncomms12311 ↗
4. An optofluidic nanoplasmonic biosensor for direct detection of live viruses from biological media10.1021/nl103025u ↗
5. Photonic crystals: emerging biosensors and their promise for point-of-care applications10.1039/C6CS00206D ↗
6. Plasmonic-based platforms for diagnosis of infectious diseases at the point-of-care10.1016/j.biotechadv.2019.107440 ↗
7. Single nanoparticle detection using photonic crystal enhanced microscopy10.1039/C3AN02295A ↗
8. Recent advances in micro/nanotechnologies for global control of hepatitis B infection10.1016/j.biotechadv.2014.11.003 ↗
9. Engineering long shelf life multi-layer biologically active surfaces on microfluidic devices for point of care applications10.1038/srep21163 ↗
10. American Cancer Society. Can infections cause cancer? (2016).
11. An alternative medical diagnosis method: biosensors for virus detection10.3390/bios9020065 ↗
12. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study global burden10.1001/jamaoncol.2016.5688 ↗
13. National Public Radio-Health. Liver cancer is becoming a top killer in poor countries. (2016).
14. Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries; Editors: Frank A Sloan and Hellen Gelband. The cancer burden in low- and middle-income countries and how it is measured. (2007).
15. Holmes · 2017
16. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
17. American Cancer Society. Key statistics about liver cancer. (2016). Available at: https://www.cancer.org/cancer/liver-cancer/about/what-is-key-statistics.html. (Accessed: 26th November 2018)
18. Hepatocellular carcinoma in developing countries: prevention, diagnosis and treatment10.4254/wjh.v4.i3.99 ↗
19. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA Level10.1001/jama.295.1.65 ↗
20. High-throughput characterization of HIV-1 reservoir reactivation using a single-cell-in-droplet PCR assay10.1016/j.ebiom.2017.05.006 ↗
21. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges10.2217/fvl.13.11 ↗
22. Prevalence of HIV and Hepatitis B virus co-infection in Sub-Saharan Africa and the potential impact and program feasibility of Hepatitis B surface antigen screening in resource-limited settings10.1097/QAI.0000000000000496 ↗
23. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings10.1016/j.jhep.2018.05.017 ↗
24. Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays10.1016/j.jviromet.2013.06.036 ↗
25. Electrical pulse-induced electrochemical biosensor for hepatitis E virus detection10.1038/s41467-019-11644-5 ↗
26. Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine10.1038/s41551-017-0082 ↗
27. Patterned photonic nitrocellulose for pseudopaper ELISA10.1021/acs.analchem.7b01732 ↗
28. Portable microfluidic integrated plasmonic platform for pathogen detection10.1038/srep09152 ↗
29. Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE 2 RD) for diagnostics10.1073/pnas.1510824112 ↗
30. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood10.1021/nn3036232 ↗
31. Construction of P-glycoprotein incorporated tethered lipid bilayer membranes
32. Flexible localized surface plasmon resonance sensor with metal–insulator–metal nanodisks on PDMS substrate10.1038/s41598-018-30180-8 ↗
33. Plasmonic gold mushroom arrays with refractive index sensing figures of merit approaching the theoretical limit10.1038/ncomms3381 ↗
34. Phase-sensitive plasmonic biosensor using a portable and large field-of-view interferometric microarray imager10.1038/lsa.2017.152 ↗
35. Recent advances in nanoplasmonic biosensors: applications and lab-on-a-chip integration10.1515/nanoph-2016-0101 ↗
36. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring10.1016/j.addr.2016.05.018 ↗
37. Advances in nanotechnology and microfluidics for human papillomavirus diagnostics10.1109/JPROC.2014.2384836 ↗
38. Molecular fingerprints of hemoglobin on a nanofilm chip10.3390/s18093016 ↗
39. Microfluidics-based diagnostics of infectious diseases in the developing world10.1038/nm.2408 ↗
40. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor10.1038/nbt.2886 ↗
41. Multiplexed profiling of single extracellular vesicles10.1021/acsnano.7b07060 ↗
42. A guide to aid the selection of diagnostic tests10.2471/BLT.16.187468 ↗
43. Diagnostic point-of-care tests in resource-limited settings10.1016/S1473-3099(13)70250-0 ↗
44. Self-assembly of gold nanoparticles at the surface of amine- and thiol-functionalized boron nitride nanotubes10.1021/jp072958n ↗
45. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance10.1002/hep.29800 ↗
46. Optical constants of the noble metals10.1103/PhysRevB.6.4370 ↗
47. A rapid label-free method for quantitation of human immunodeficiency virus type-1 particles by nanospectroscopy10.1016/j.jviromet.2012.03.012 ↗
48. Counting and differentiating aquatic biotic nanoparticles by full-field interferometry : from laboratory tests to Tara Oceans sample analysis10.1364/BOE.7.003736 ↗
49. An introduction to error analysis: the study of uncertainties in physical measurements10.1063/1.882103 ↗